4.6 Review

Mitochondrial DNA disease-molecular insights and potential routes to a cure

期刊

EXPERIMENTAL CELL RESEARCH
卷 325, 期 1, 页码 38-43

出版社

ELSEVIER INC
DOI: 10.1016/j.yexcr.2014.03.012

关键词

Mitochondrial disease; Treatments; Zinc-finger nucleases; TALENs

资金

  1. Newcastle University Centre for Brain Ageing and Vitality - Biotechnology and Biological Sciences Research Council
  2. Engineering and Physical Sciences Research Council
  3. Economic and Social Research Council
  4. Medical Research Council [G0700718]
  5. UK NIHR Biomedical Research Centre in Age and Age Related Diseases award
  6. MRC Centre for Neuromuscular Disease [G000608-1]
  7. Wellcome Trust Centre for Mitochondrial Research [096919/Z/11/Z]]
  8. Lily Foundation
  9. UK NHS Specialist Commissioners Rare Mitochondrial Disorders of Adults and Children Service
  10. MRC [G0700718, MR/K006312/1] Funding Source: UKRI
  11. Medical Research Council [MR/K006312/1, G0700718] Funding Source: researchfish
  12. NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish

向作者/读者索取更多资源

Mitochondrial DNA diseases are common neurological conditions caused by mutations in the mitochondrial genome or nuclear genes responsible for its maintenance. Current treatments for these disorders are focussed on the management of the symptoms, rather than the correction of biochemical defects caused by the mutation. This review focuses on the molecular effects of mutations, the symptoms they cause and current work focusing on the development of targeted treatments for mitochondrial DNA disease. (C) 2014 The Authors. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据